Hilltop Holdings’s Merck MRK Stock Holding History

Hilltop Holdings’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.88M	Sell	40,564 -9,215	-19%	-$1.06M	0.44%	48
2025 Q4	$5.24M	Sell	49,779 -2,140	-4%	-$201K	0.31%	79
2025 Q3	$4.36M	Sell	51,919 -6,166	-11%	-$508K	0.23%	101
2025 Q2	$4.6M	Sell	58,085 -16,278	-22%	-$1.29M	0.29%	85
2025 Q1	$6.67M	Buy	74,363 +1,006	+1%	+$93.9K	0.42%	48
2024 Q4	$7.3M	Sell	73,357 -5,578	-7%	-$575K	0.46%	42
2024 Q3	$8.96M	Buy	78,935 +29,409	+59%	+$3.49M	0.57%	30
2024 Q2	$6.13M	Sell	49,526 -1,100	-2%	-$142K	0.71%	25
2024 Q1	$6.68M	Buy	50,626 +7,759	+18%	+$956K	0.69%	27
2023 Q4	$4.67M	Buy	42,867 +1,656	+4%	+$172K	0.53%	32
2023 Q3	$4.24M	Buy	41,211 +834	+2%	+$89.9K	0.49%	45
2023 Q2	$4.66M	Sell	40,377 -1,937	-5%	-$220K	0.57%	35
2023 Q1	$4.5M	Sell	42,314 -734	-2%	-$79.2K	0.59%	35
2022 Q4	$4.78M	Buy	43,048 +1,012	+2%	+$103K	0.61%	39
2022 Q3	$3.62M	Buy	42,036 +4,786	+13%	+$427K	0.49%	48
2022 Q2	$3.4M	Sell	37,250 -304	-0.8%	-$26.9K	0.45%	47
2022 Q1	$3.08M	Sell	37,554 -1,393	-4%	-$110K	0.35%	64
2021 Q4	$2.98M	Buy	38,947 +4,838	+14%	+$385K	0.31%	71
2021 Q3	$2.56M	Buy	34,109 +4,756	+16%	+$362K	0.28%	83
2021 Q2	$2.28M	Buy	29,353 +340	+1%	+$25.3K	0.26%	91
2021 Q1	$2.13M	Buy	29,013 +455	+2%	+$33.6K	0.28%	79
2020 Q4	$2.23M	Buy	28,558 +4,295	+18%	+$328K	0.31%	71
2020 Q3	$1.92M	Buy	24,263 +3,898	+19%	+$305K	0.33%	72
2020 Q2	$1.5M	Buy	20,365 +4,092	+25%	+$308K	0.28%	85
2020 Q1	$1.2M	Sell	16,273 -7,163	-31%	-$563K	0.29%	82
2019 Q4	$2.03M	Sell	23,436 -10,239	-30%	-$841K	0.38%	62
2019 Q3	$2.71M	Sell	33,675 -4,148	-11%	-$332K	0.51%	49
2019 Q2	$3.03M	Sell	37,823 -4,811	-11%	-$368K	0.64%	41
2019 Q1	$3.38M	Buy	42,634 +16,520	+63%	+$1.24M	0.72%	31
2018 Q4	$1.9M	Buy	26,114 +10,124	+63%	+$715K	0.47%	53
2018 Q3	$1.08M	Sell	15,990 -7,149	-31%	-$455K	0.23%	113
2018 Q2	$1.34M	Sell	23,139 -1,406	-6%	-$79.3K	0.28%	94
2018 Q1	$1.28M	Sell	24,545 -5,381	-18%	-$291K	0.22%	112
2017 Q4	$1.61M	Buy	29,926 +7,659	+34%	+$425K	0.36%	78
2017 Q3	$1.36M	Sell	22,267 -8,760	-28%	-$531K	0.41%	77
2017 Q2	$1.9M	Sell	31,027 -561	-2%	-$34.1K	0.56%	49
2017 Q1	$1.92M	Sell	31,588 -3,297	-9%	-$200K	0.58%	45
2016 Q4	$1.96M	Sell	34,885 -4,265	-11%	-$250K	0.61%	41
2016 Q3	$2.33M	Buy	39,150 +395	+1%	+$23.1K	0.73%	36
2016 Q2	$2.13M	Buy	38,755 +3,600	+10%	+$192K	0.68%	39
2016 Q1	$1.77M	Sell	35,155 -4,683	-12%	-$229K	0.56%	48
2015 Q4	$2.01M	Sell	39,838 -27	-0.1%	-$1.36K	0.58%	45
2015 Q3	$1.88M	Buy	39,865 +738	+2%	+$39.2K	0.55%	47
2015 Q2	$2.13M	Sell	39,127 -828	-2%	-$46.4K	0.58%	51
2015 Q1	$2.19M	Buy	39,955 +11,798	+42%	+$668K	0.56%	49
2014 Q4	$1.53M	Buy	28,157 +1,132	+4%	+$63.1K	0.53%	43
2014 Q3	$1.53M	Buy	27,025 +8,012	+42%	+$450K	0.7%	35
2014 Q2	$1.05M	Sell	19,013 -23	-0.1%	-$1.25K	0.49%	64
2014 Q1	$1.03M	Buy	19,036 +4,687	+33%	+$243K	0.51%	60
2013 Q4	$685K	Buy	14,349 +1,898	+15%	+$86.8K	0.35%	81
2013 Q3	$566K	Buy	12,451 +4,288	+53%	+$196K	0.33%	86
2013 Q2	$361K	Buy	+8,163	New	+$365K	0.24%	101

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hilltop Holdings's MRK Position: Q1 2026 in Review

Hilltop Holdings reduced its Merck (MRK) stake by 19% in Q1 2026, selling an estimated $1.06M and leaving 40,564 shares worth $4.88M. The position accounts for 0.44% of the portfolio, ranked #48.

Hilltop Holdings first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.96M in Q3 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Hilltop Holdings held 40,564 shares of Merck worth $4.88M as of Q1 2026.
Hilltop Holdings sold 9,215 Merck shares in Q1 2026, an estimated $1.06M.
Merck made up 0.44% of Hilltop Holdings's portfolio in Q1 2026, its #48 holding.
Hilltop Holdings first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Hilltop Holdings's Merck position peaked at $8.96M in Q3 2024.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hilltop Holdings's 13F filing for Q1 2026, filed 14 May 2026.